LOADING
Comparing Johnson & Johnson (JNJ) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | QCOM |
|---|---|---|
| Price | $252.68 | $149.56 |
| Change Today | -1.43% | +1.32% |
| Market Cap | $617.8B | $155.0B |
| P/E Ratio | 29.8 | 16.9 |
| Forward P/E | 22.0 | 14.0 |
| PEG Ratio | 4.23 | 0.63 |
| EPS | $8.61 | $8.75 |
| Revenue Growth (YoY) | 6.6% | -4.0% |
| Profit Margin | 21.5% | 21.0% |
| Return on Equity | 25.7% | 33.8% |
| Dividend Yield | 2.05% | 2.37% |
| Beta | 0.23 | 1.64 |
| 52-Week High | $274.90 | $258.96 |
| 52-Week Low | $162.56 | $121.54 |
| Volume | 118K | 229K |
Johnson & Johnson is the larger company by market capitalization. Qualcomm Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Qualcomm Inc offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.